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Morinda citrifolia is a medicinal plant used to treat diabetes and liver diseases. The fermented fruit juice of the M. Citrifolia
(opticaldensity=1.25)wasusedtostudythehypoglycemicandhepatoprotectivepropertiesindiabetes-inducedrats.Theratswere
randomly distributed into 4 groups (control, diabetic experimental, diabetic standard, and diabetic untreated) of 6 each. Diabetes
was induced by administering Streptozotocin (50mg/kg body weight). Fasting blood glucose, body mass, liver tissue glycogen
content, and the extent of liver degeneration were assessed. Diabetic experimental animals were treated with M. citrifolia juice
(2ml/kg, twice a day) and diabetic standard with reference hypoglycemic drug, glibenclamide orally for 20 days. Both the groups
exhibited a signiﬁcant reduction in blood glucose level of 150mg/dl ±15.88 and 125mg/dl ±3.89, respectively, as compared to
diabeticuntreatedwithFBS=360.0mg/dl ±15.81,(P<. 003).On10thdayofexperiment,diabeticexperimentalanimalsexhibited
a decrease in body mass (10.2g, 5.11%) which increased signiﬁcantly by the 20th day (6g, 3.0%, P<. 022). Histological study of
liver tissue obtained from untreated diabetic animals revealed signiﬁcant fatty degeneration as compared to other three groups.
The data of this study proved the hypoglycemic and hepatoprotective activity of M. citrifolia.
1.Introduction
Diabetes mellitus (DM) is a group of metabolic disorders
characterized by hyperglycemia, with disturbances of carbo-
hydrate, fat, and protein metabolism resulting from defects
in insulin secretion, insulin action, or both. Regulation of
the major metabolic pathways involved in fat, carbohydrate,
and protein is of critical importance to bodily function
and is achieved by several hormones. Insulin, a pancreatic
hormone,isessentialintheregulationofcarbohydrate,lipid,
and protein metabolism. It functions to preserve and to
create energy reserves in the body by inhibiting catabolic
processes such as lipolysis, gluconeogenesis, proteolysis,
and glycogenolysis. Insulin promotes glycogenesis, fatty-acid
synthesis, intestinal amino-acid uptake, and plasma glucose
uptake [1, 2].
Underproduction of, or insensitivity of cells to insulin
or a combination of, both represents the core aetiology
of diabetes mellitus. Management of diabetes mellitus is
based upon mechanisms which increase insulin secretion.
Secretagogues sensitize cells to insulin, and sensitizers inhibit
intestinal glucose absorption and reduce gastric emptying.
Current treatment methods, although quite eﬀective, can
have undesirable side eﬀects. Additionally, continuous use
of the medications listed above may constitute an economic
burden on the user [3].
Naturalremediesfrommedicinalplantsareconsideredto
be eﬀective and safe alternative treatment for hyperglycemia
and liver toxicity. There is a growing interest in herbal
remedies because of their eﬀectiveness, minimal side eﬀects
in clinical experience, and relatively low cost. Herbal drugs
or their extracts are prescribed widely, even when their
biological active compounds are unknown [4]. Therefore,
studies with plant extracts are useful to know their eﬃcacy
and mechanism of action and safety.
In Trinidad and Tobago, a large variety of plants have
been employed by contemporary traditional healers in the
management of diabetes based on their received medici-
nal beneﬁt. These include Momordica charantia (Caraaili),
Carica papaya (Paw-paw), Catharanthus roseus (white peri-
winkle), Neurolaena lobata (Zebapique), Cecropia peltata
(trumpet Bush), Cordia curassavica (Black Sage), and Bontia2 Evidence-Based Complementary and Alternative Medicine
daphnoides (Olive Bush). Users of these plants have claimed
signiﬁcant therapeutic beneﬁts that, at times, may even
exceed the clinical beneﬁts of modern drugs [5, 6].
Morinda citrifolia L (Rubiaceae) also known as noni, or
Indian mulberry, is a small evergreen tree. It is native to the
Paciﬁc islands, Polynesia, Asia, and Australia. The leaves are
8ormoreincheslongandareovalinshape.Thefruitis3to4
inches in diameter with a warty, pitted surface. M. citrifolia is
one of the most important traditional Polynesian medicinal
plants and has been heavily promoted for a wide range
of uses; from arthritis and burns to circulatory weakness,
diabetes, cancer, skin inﬂammation, and wounds [7–10].
2. Methods
2.1. Preparation of Aqueous Fermented Extract. Freshly har-
vested ripe noni fruits were collected from a local supplier.
The fruit was thoroughly washed in luke warm water to
remove fungus and to retard the growth of microbiological
organisms that may be sensitive to heat. The noni fruit was
then cut into pieces to ﬁt into a 2000ml container and
500ml of water was then added. The chunked (noni) fruit
was left to ferment for 6–10 weeks at room temperature.
At the end of the fermentation period, 400ml of stock
(noni) ferment was transferred to a 1000ml container. The
400mlstockfermentwasﬁlteredusingWhatmanﬁlterpaper
and vacuum ﬁltration to eliminate debris and fruit particles
from the stock solution. Thirty millilitres of the ﬁltrated
ferment was used for qualitative phytochemical analysis
and 10ml was used for UV/VIS spectroanalysis and optical
density determination. The remaining 360ml was used for
the experiment.
2.2. ExperimentalDesign. Healthy Sprague-Dawleymale rats
weighing between 200 and 220g were used for the study.
The animals were individually housed and maintained on
normal food and water ad libitum. Animals were periodically
weighed before and after experiments. Fasting blood glucose
levels of the animals were assessed using the glucometer,
which employed the glucose oxidase/peroxidase reaction.
Blood for glucose estimation was obtained from the tail
veins of the rats. All animals were closely observed for any
infection, and those that showed signs of infection were
separated and excluded from the study. The study was
approved by the Ethics Committee of the (EC-A/5-2009)
Faculty of Medical Sciences, The University of the West
Indies, St. Augustine. The rats were randomly distributed
into 4 groups of 6 each as follows:
(a) normal control group: this group received only food
and water,
(b) diabetic experimental group: In addition to food
and water, this group received fermented juice of M.
citrifolia (OD = 1.2470 at 338nm) orally at a dose
of 2ml/kg twice daily for 20 days from the day of
diabetes induction,
(c) diabetic standard group: in addition to food and
water, this group received glibenclamide, dissolved in
DMSO at a dose of 2.0mg/kg/day orally for 20 days,
(d) diabetic untreated group: this group of rats was
provided food and water.
All the groups were provided food and water ad libitum.
2.3. Induction of Diabetes Mellitus. Diabetes was induced
by administering 50mg/kg of Streptozotocin in cold citrate
buﬀer, pH 4.5, intraperitoneally to overnight fasted adult
Sprague-Dawley rats. After three days, animals with a fasting
blood glucose >200mg were considered to be diabetic.
2.4. Histological Study. Liver was obtained on day 20 from all
the groups of animals for the histological study. The tissues
were ﬁxed in 10% buﬀered formal saline and processed
for routine histological evaluation. Sections of 7.0micron
were cut from the tissues, some of which were stained with
Periodic Acid Schiﬀ (PAS) and the rest with Haematoxylin
and Eosin.
2.5. Statistical Analysis. The means of fasting blood glucose
andbodymassbetweengroupsatdiﬀerenttimeintervalswas
compared using One-way ANOVA, descriptive test, followed
by Dunnett’s post hoc test. Data was analyzed using the SPSS
(Version 16.0, Chicago, USA). Diﬀerences between groups
were considered signiﬁcant at P<. 05 levels.
3. Results
3.1. Phytochemical Analysis. Qualitative phytochemical anal-
ysis of fermented juice of M. citrifolia revealed the presence
of saponins, triterpenes, steroids, ﬂavonoids, and cardiac
glycosides.
3.2. Fasting Blood Glucose. On the 20th day, after treatment,
there was a signiﬁcant normalization of fasting blood
sugar, observed in diabetic experimental animals treated
with M. citrifolia and the diabetic standard with reference
hypoglycaemic drug, glibenclamide as compared to diabetic
untreated animals. In diabetic experimental animals, there
was a signiﬁcant decrease in fasting glucose from an excess of
300mg/dl(day3)to150mg/dl(day20),andthisrepresented
a decrease of 52.6%. The diabetic standard group showed
the reduction in fasting blood sugar from 250mg/dl to
125mg/dl. The decrease in fasting blood glucose levels was
not observed with the untreated diabetic animals (Figure 2).
3.3. Body Mass Variation. In the latter 10 days of the treat-
ment period, diabetic experimental and diabetic standard
group animals exhibited a signiﬁcant increase in body mass
of 3.0 and 8.0 percent, respectively, whereas the diabetic
untreated animals showed a decrease in body mass, (16.3g,
8.17%) over the course of the 20-day treatment period
(Figure 1)( P<. 022).
3.4. Histological Analysis. Histological analysis of the liver
tissue obtained from the untreated animals revealed a
signiﬁcant fatty degeneration (Figure 5), as compared to the
liver tissue obtained from the normal control (Figure 3)Evidence-Based Complementary and Alternative Medicine 3
0
50
100
150
200
250
Basaline-D
I D-1
5th-PTI 10th-PTI 15th-PTI 20th-PTI
B
o
d
y
m
a
s
s
(
g
)
(days)
V a r i a t i o no fb o d ym a s si nd i a b e t i ca n i m a l s
Normal
Diabetic + standard
Diabetic untreated
3rd-
PDI-TS
Diabetic + noni
DI = diabetes induced
TS = treatment started
PDI = postdiabetic induction
PTI = posttreatment initiation
Figure 1: Body mass of normal control, diabetic experimental,
diabetic standard, and diabetic untreated measured at basal level
(before treatment) and during 20 days of drug treatment; (n =
6) each column represents mean ±SE. (∗P<. 022) versus
diabetic untreated (One-way ANOVA, descriptive test, followed by
Dunnett’s multiple comparison post hoc test).
and diabetic experimental animals treated with M. citrifolia
(Figure 4). Hepatocytes of the untreated diabetic animals
were irregularly shaped, and numerous large fatty inﬁltrates
were seen (Figure 5) in the cytoplasm of 35% of those liver
cells as compared to the normal control (Figure 3), dia-
betic experimental (Figure 4), and diabetic standard animals
(Figure 6).
4. Discussion
Fasting blood sugar in diabetic rats represents an important
indicator of diabetic status. The results of this study clearly
indicate that the eﬀect of M. citrifolia fruit juice is equivalent
to the reference oral hypoglycemic drug, glibenclamide.
Indeed, both treatments signiﬁcantly reduced hyper-
glycemia. The constituents of noni juice might have lowered
glucose levels either by promoting insulin secretion like
sulphonylurias or gliptines or by increasing insulin receptor
sensitivity like biguanides and glitazones. Recently, scientists
showed a similar phenomenon of hypoglycaemic action with
the extracts of Argania spinosa and C. Dactylon [11, 12].
Animalstreatedwithfermentednonifruitjuiceexhibited
(3.0%) increase in body mass in the ﬁnal 10 days of treat-
ment.Conversely,untreateddiabeticanimalsdemonstrateda
(8.17%) decrease in body mass over the same period of time.
Untreated diabetic animals were consuming more amount of
water when compared to the noni juice-treated rats.
Diabetic rats treated with noni juice had reduced the
hepatocyte fatty degeneration (fatty globules were smaller
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Figure 2: Fasting blood glucose of normal control, diabetic
experimental,diabeticstandard,anddiabeticuntreatedmeasuredat
basal level (before treatment) and during 20 days of drugtreatment;
(n = 6) each line represents mean ±SE. (∗P<. 003) versus
diabetic untreated (One-way ANOVA, descriptive test, followed by
Dunnett’s multiple comparison post hoc test).
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Figure 3: Histology of the liver specimen obtained from normal
control animal (PAS-stain). No fatty inﬁltrates were observed in
the liver specimen above. Glycogen granules were well distributed
thoroughout the slide area.
and less numerous) when compared to diabetic untreated
animals. This suggests a possible hepatoprotective property
of the fermented noni juice. Wang et al. demonstrated the
hepatoprotective activity of noni fruit juice against CCL4-
induced liver damage [13]. Recently, researchers showed
that the Indian honey protects liver against oxidative dam-
age and it could be used as an eﬀective hepatoprotector
against Acetaminophen-induced liver damage [14]. The liver4 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Histology of the liver specimen obtained from M.
Citrifolia-treated animals (PAS-stain). Few small fatty Inﬁltrates
were observed in the liver specimen above. Glycogen granules were
well distributed thorough-out the slide area.
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Figure 5: Histology of the liver specimen obtained from untreated
diabetic animals (PAS-stain). Numerous large fat cells were seen in
the cytoplasm of numerous hepatocytes. Glycogen deposition was
sparse and irregular. Morphology of hepatocyte was also altered by
the presence of the fatty globules.
protecting activity was well correlated with its antioxidant
properties. After analyzing our results and previous reports
on M. citrifolia, we hypothesize that the hepatoprotective
activity of M. citrifolia is due to its possible antioxidant
properties of its ﬂavonoid constituents.
The hypoglycaemic activity, exhibited by the noni fruit
ferment, may be attributed to the presence of triterpenes
and saponins. Researchers demonstrated the presence of a
signiﬁcant quantity of bioactive compounds like ﬂavonoids,
triterpenoids, triterpenes, and saponins in Morinda citrifolia
[15,16].Ithasbeensuggestedthatsaponinsmaysigniﬁcantly
inhibit gastric emptying [17, 18]. The saponins could inhibit
gastric emptying either by promoting secretion of glucagon
like peptides-1 (GLP-1) or by inhibiting its degradation.
This drug-induced gastroparesis is an eﬀective method of
managing hyperglycemia because it slows the process of
nutrientabsorptionintothebloodstream.Also,thepresence
of saponin in M. citrifolia may have a glucagon decreasing
Glycogen
granules
Nucleus of
hepatocyte
50µm
Figure 6: Histology of the liver specimen obtained from diabetic
standard animals (PAS-stain). Well-organised glycogen granules
were seen.
eﬀect and may enhance glucose utilization lowering blood
glucose. It is also reported that saponin stimulates insulin
release from the pancreas [19]( Figure 7), and it could be
due to decreased degradation of glucagon like peptides. On
the other hand, glibenclamide exerts hypoglycemic action by
stimulation of insulin secretion and inhibition of glucagon
release. The remaining intact pancreatic cells are stimulated
by M. citrifolia or glibenclamide, and the serum insulin
level is increased, and the blood glucose is decreased.
Rutin is a ﬂavonoid (a glycoside composed of rutinose and
quercetin) found in signiﬁcant quantities in the noni fruit,
and it is postulated that the rutinose residues may act as
a secretagogue, which potentiates insulin secretion by a
mechanism related to that of sugar sucrose. Triterpenoids
have also been indicated as possible therapeutic agents that
can be beneﬁcial in the management of diabetes mellitus,
as they have been shown to be eﬀective in improving
symptoms of glycosuria and blood sugar in alloxan-induced
mice [20, 21]. The above are preliminary indications, and
further detailed studies are necessary to ﬁnd out whether the
action of the fruit juice is due to one or more of the above-
mentioned possible mechanisms or not. Thus, the fermented
fruit juice of M. citrifolia seems to be useful in controlling
blood sugar and hepatic injury. Puriﬁcation of noni fruit
juice and identiﬁcation of the active principle may yield a
good hypoglycaemic and hepatoprotective drug.
5. Conclusions
Data of this study showed that fermented juice of M.
citrofolia may possess hypoglycemic and hepatoprotective
properties based on the parameters examined. Morinda
citrofolia signiﬁcantly improved the fasting glucose status of
diabetic animals over the period of twenty days. There was
also an observed increase in body mass. It can be presumed
that M. citrofolia either potentiates the action of insulin
directly or that it increases peripheral tissue sensitivity to
the storage hormone. It may have the capacity to improve
fat metabolism and as such reduce fatty accumulation in theEvidence-Based Complementary and Alternative Medicine 5
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Figure 7:Schematicdiagramshowingthepossibleroleofnonifruit
juice constituents in reducing blood sugar.
liver. Nonetheless, clinical studies are required to assess the
potential beneﬁt of M. citrofolia preparations in humans.
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